277 related articles for article (PubMed ID: 27733759)
1. Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE.
Dörner T; Lipsky PE
Nat Rev Rheumatol; 2016 Nov; 12(11):645-657. PubMed ID: 27733759
[TBL] [Abstract][Full Text] [Related]
2. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
3. New treatments for SLE: cell-depleting and anti-cytokine therapies.
Anolik JH; Aringer M
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
[TBL] [Abstract][Full Text] [Related]
4. Belimumab therapy in systemic lupus erythematosus.
Zouali M; Uy EA
BioDrugs; 2013 Jun; 27(3):225-35. PubMed ID: 23568179
[TBL] [Abstract][Full Text] [Related]
5. New therapeutic avenues in SLE.
Bakshi J; Ismajli M; Rahman A
Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):794-809. PubMed ID: 27107514
[TBL] [Abstract][Full Text] [Related]
6. Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus.
Sthoeger Z; Sharabi A; Mozes E
J Autoimmun; 2014 Nov; 54():60-71. PubMed ID: 24958634
[TBL] [Abstract][Full Text] [Related]
7. B-cell biology and related therapies in systemic lupus erythematosus.
Ahmed S; Anolik JH
Rheum Dis Clin North Am; 2010 Feb; 36(1):109-30, viii-ix. PubMed ID: 20202594
[TBL] [Abstract][Full Text] [Related]
8. B cells in SLE: different biological drugs for different pathogenic mechanisms.
Diamanti AP; Rosado MM; Carsetti R; Valesini G
Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325
[TBL] [Abstract][Full Text] [Related]
9. Rituximab: a promising therapy in systemic lupus erythematosus.
Thatayatikom A; White AJ
Autoimmun Rev; 2006 Jan; 5(1):18-24. PubMed ID: 16338207
[TBL] [Abstract][Full Text] [Related]
10. Belimumab: a guide to its use in systemic lupus erythematosus.
Scott LJ; Burness CB; McCormack PL
BioDrugs; 2012 Jun; 26(3):195-9. PubMed ID: 22428610
[TBL] [Abstract][Full Text] [Related]
11. Targeting B cells with biologics in systemic lupus erythematosus.
La Cava A
Expert Opin Biol Ther; 2010 Nov; 10(11):1555-61. PubMed ID: 20919800
[TBL] [Abstract][Full Text] [Related]
12. Belimumab for the treatment of systemic lupus erythematosus.
Jordan N; D'Cruz DP
Expert Rev Clin Immunol; 2015 Feb; 11(2):195-204. PubMed ID: 25543845
[TBL] [Abstract][Full Text] [Related]
13. Progress with the use of monoclonal antibodies for the treatment of systemic lupus erythematosus.
Jordan N; Lutalo PM; D'Cruz DP
Immunotherapy; 2015; 7(3):255-70. PubMed ID: 25804478
[TBL] [Abstract][Full Text] [Related]
14. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
Yoshizaki A
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
Goldblatt F; Isenberg DA
Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
[TBL] [Abstract][Full Text] [Related]
16. Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus.
Gatto M; Depascale R; Stefanski AL; Schrezenmeier E; Dörner T
Best Pract Res Clin Rheumatol; 2023 Dec; 37(4):101864. PubMed ID: 37625930
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery.
Sutter JA; Kwan-Morley J; Dunham J; Du YZ; Kamoun M; Albert D; Eisenberg RA; Luning Prak ET
Clin Immunol; 2008 Mar; 126(3):282-90. PubMed ID: 18226586
[TBL] [Abstract][Full Text] [Related]
18. Epratuzumab for systemic lupus erythematosus.
Wallace DJ; Goldenberg DM
Lupus; 2013 Apr; 22(4):400-5. PubMed ID: 23553783
[TBL] [Abstract][Full Text] [Related]
19. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
20. SLE - Rituximab in lupus.
Eisenberg R
Arthritis Res Ther; 2003; 5(4):157-9. PubMed ID: 12823844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
